How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	909-910
Number of pages	2
Journal	Journal of Cardiovascular Electrophysiology
Volume	36
Issue number	4
DOIs	https://doi.org/10.1111/jce.16591
State	Published - 2025/04

ASJC Scopus subject areas

@article{7295036be914483583fcee8247a469c7,

title = "How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation",

author = "Naoya Kataoka and Teruhiko Imamura",

year = "2025",

month = apr,

doi = "10.1111/jce.16591",

language = "英語",

volume = "36",

pages = "909--910",

journal = "Journal of Cardiovascular Electrophysiology",

issn = "1045-3873",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

AU - Kataoka, Naoya

AU - Imamura, Teruhiko

PY - 2025/4

Y1 - 2025/4

UR - http://www.scopus.com/inward/record.url?scp=85216943727&partnerID=8YFLogxK

U2 - 10.1111/jce.16591

DO - 10.1111/jce.16591

M3 - Letter

C2 - 39909837

AN - SCOPUS:85216943727

SN - 1045-3873

VL - 36

SP - 909

EP - 910

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

IS - 4

ER -